British pharmaceutical giant GlaxoSmithKline and rival Pfizer have agreed to end a lawsuit that alleged Pfizer's respiratory ...

In 2020, many companies tried to develop effective coronavirus vaccines, but two ended up succeeding and dominating the field ...

Moderna's mRNA technology gained rapid validation as sales of its covid vaccine soared in 2021 and 2022, but we think the firm has yet to secure a narrow economic moat around its business, largely due ...

The FDA has delayed granting full approval of Novavax's COVID-19 vaccine despite it being on track to be cleared until ...

The delayed decision comes amid a major organizational shakeup that included the departure of top vaccine official Peter ...

The US Food and Drug Administration was supposed to make a final decision about whether or not to approve Novavax's (NVAX) COVID-19 vaccine this week, but that deadline has passed with no clarity on ...

Amid a period of great upheaval at the agency, the FDA has missed its deadline to decide on approval for Novavax’s COVID-19 ...

Where can I buy a Covid vaccine and what does it cost? A number of High Street chemists and private clinics sell and administer the Pfizer Covid vaccine directly to the public. The cost per single ...

Ex-vaccine regulator Peter Marks promoted "ineffective therapy that gave patients false hope, eroded trust in the regulatory ...

The group had a bad week after turmoil at the FDA, continuing a long period of underperformance following the pandemic.

Moderna, Baxter, and Pfizer are our top healthcare picks.

Significant layoffs across the FDA, CDC and NIH are ushering in a new era of public health under the Trump administration.